David Flockhart

David A. Flockhart (1952–2015) was a Scottish medical researcher who was a leader in the field of personalised medicine. He was especially known for his work on factors affecting the use of tamoxifen to treat breast cancer such as variability in the level of the CYP2D6 enzyme.

References

{{reflist|refs=

{{citation |newspaper=The Economist |page=84 |title=In death, there is life |date=26 March 2016}}

{{citation |newspaper=Edinburgh Evening News |title=David Flockhart : Obituary |date=3 December 2015 |url=http://announce.jpress.co.uk/edinburgh-evening-news-and-scotsman-publications/obituary/david-flockhart/44255214}}

{{citation |publisher=Indiana University Department of Medicine |title=In Memoriam, David A. Flockhart PhD, MD |date=26 November 2015 |url=http://medicine.iupui.edu/about/flockhart}}

}}

Category:1952 births

Category:2015 deaths

Category:20th-century Scottish medical doctors

Category:Indiana University School of Medicine faculty